The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia
To best control tumor growth and/or metastasis in triple negative breast cancer (TNBC), it may be useful to understand the effect(s) of chemotherapy delivery (i.e., the rate and pattern of exposure to the drug) on cell sub-populations that have experienced different levels of hypoxia (and/or acidosi...
Saved in:
Main Authors: | Omkar Bhatavdekar (Author), Inês Godet (Author), Daniele Gilkes (Author), Stavroula Sofou (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
by: Dominick Salerno, et al.
Published: (2021) -
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021) -
Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers
by: Dominick Salerno, et al.
Published: (2022) -
Targeted Treatment of Metastatic Triple-Negative Breast Cancer: A Systematic Review
by: Anna Martha Hammershøi Madsen, et al.
Published: (2024) -
Palmatine Attenuates Metastatic Lung Colonization of Triple Negative Breast Cancer Cells
by: Selase Ativui, et al.
Published: (2022)